Physician profile
Sandi E Engler
NPI 1588643860
$6,696.48
in general payments reported to CMS, 2019-2025
57 companies · $1,091 in 2025
The $1,091 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,222 · 2022: $1,582 · 2023: $1,443 · 2024: $1,359 · 2025: $1,091.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,892.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $790.87 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $639.32 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Sanofi-Aventis U.S. LLC | $418.81 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $339.03 | 2021-2025 | Trintellix |
| Glaxosmithkline, LLC. | $332.74 | 2021-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $266.53 | 2021-2024 | Mounjaro, Jardiance, Trulicity |
| Supernus Pharmaceuticals, INC. | $256.49 | 2024 | Qelbree |
| Novo Nordisk INC | $251.58 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Otsuka America Pharmaceutical, INC. | $239.21 | 2021-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $217.72 | 2024-2025 | Caplyta |
| Novartis Pharmaceuticals Corporation | $217.04 | 2021-2025 | |
| Pfizer INC. | $209.89 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $189.45 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $188.69 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $141.60 | 2023-2024 | Gemtesa |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $139.73 | 2022-2025 | Rexulti |
| Amgen INC. | $133.58 | 2021-2025 | Otezla, Repatha, Repatha |
| Sunovion Pharmaceuticals INC. | $124.70 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.31 | 2023-2025 | Jardiance, Synjardy, Tradjenta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $112.17 | 2021-2023 | Xifaxan |
| Esperion Therapeutics, INC. | $96.50 | 2021-2024 | Nexletol |
| Merck Sharp & Dohme LLC | $92.89 | 2021-2025 | Gardasil 9, Capvaxive |
| Dexcom, INC. | $88.28 | 2021-2023 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $84.70 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Xeris Pharmaceuticals, INC. | $64.57 | 2021-2023 | Gvoke Hypopen |
| Phathom Pharmaceuticals, INC. | $63.61 | 2024 | Voquezna |
| Abbott Laboratories | $60.85 | 2021-2025 | Freestyle Libre 3 |
| Medtronic, INC. | $58.26 | 2022-2023 | Intellis Adaptivestim |
| Corium, LLC | $56.05 | 2023 | Azstarys |
| Boston Scientific Corporation | $55.07 | 2023-2024 | Wavewriter Alpha Prime 16, Spectra Wavewriter |
| Jazz Pharmaceuticals INC. | $47.02 | 2021-2022 | |
| Astellas Pharma US INC | $46.62 | 2025 | Veozah |
| Eisai INC. | $38.66 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $38.64 | 2022-2023 | Evkeeza, Praluent |
| Acadia Pharmaceuticals INC | $35.50 | 2021-2022 | |
| Axonics, INC. | $31.62 | 2022 | |
| Antares Pharma, INC. | $28.86 | 2022-2023 | Nocdurna, Tlando, Xyosted |
| Intuity Medical INC | $25.54 | 2022 | |
| Acerus Pharmaceuticals Corporation | $25.53 | 2022 | |
| Gilead Sciences, INC. | $24.20 | 2023 | |
| Ironwood Pharmaceuticals, INC | $24.00 | 2021 | |
| Urovant Sciences INC | $23.98 | 2022 | |
| Axsome Therapeutics, INC. | $23.26 | 2025 | Auvelity |
| Philips North America LLC | $23.09 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Idorsia Pharmaceuticals US INC | $21.22 | 2023 | Quviviq |
| Ultragenyx Pharmaceutical INC. | $19.59 | 2022 | |
| Viatris Specialty LLC | $18.51 | 2025 | Yupelri |
| Nestle Healthcare Nutrition INC. | $18.50 | 2021 | |
| Renalytix Ai, INC. | $15.83 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Biohaven Pharmaceuticals, INC. | $15.79 | 2021 | |
| Almatica Pharma LLC | $15.43 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $15.10 | 2022 | |
| Biodelivery Sciences International, INC. | $15.08 | 2021 | |
| Avanir Pharmaceuticals, INC. | $14.71 | 2022 | |
| Mylan Specialty L.P. | $14.33 | 2024 | Yupelri |
| Vbi Vaccine (Delaware) INC. | $12.96 | 2022 | |
| Genentech USA, INC. | $11.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandi Engler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.